Takahiro Hasebe

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Important histologic outcome predictors for patients with invasive ductal carcinoma of the breast.

Important histologic outcome predictors for patients with invasive ductal carcinoma of the breast.

Journal: The American journal of surgical pathology

Published: September 02, 2011

Modified primary tumour/vessel tumour/nodal tumour classification for patients with invasive ductal carcinoma of the breast.

Modified primary tumour/vessel tumour/nodal tumour classification for patients with invasive ductal carcinoma of the breast.

Journal: British journal of cancer

Published: August 04, 2011

Atypical tumor-stromal fibroblasts in invasive ductal carcinoma of the breast.

Atypical tumor-stromal fibroblasts in invasive ductal carcinoma of the breast.

Journal: The American journal of surgical pathology

Published: February 15, 2011

Prognostic significance of mitotic figures in metastatic mammary ductal carcinoma to the lymph nodes.

Prognostic significance of mitotic figures in metastatic mammary ductal carcinoma to the lymph nodes.

Journal: Human pathology

Published: January 13, 2011

Atypical tumor-stromal fibroblasts in invasive ductal carcinomas of the breast treated with neoadjuvant therapy.

Atypical tumor-stromal fibroblasts in invasive ductal carcinomas of the breast treated with neoadjuvant therapy.

Journal: Human pathology

Published: July 19, 2010

Grading system for lymph vessel tumor emboli: significant outcome predictor for patients with invasive ductal carcinoma of the breast who received neoadjuvant therapy.

Grading system for lymph vessel tumor emboli: significant outcome predictor for patients with invasive ductal carcinoma of the breast who received neoadjuvant therapy.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: February 02, 2010

p53 expression in tumor stromal fibroblasts is associated with the outcome of patients with invasive ductal carcinoma of the breast.

p53 expression in tumor stromal fibroblasts is associated with the outcome of patients with invasive ductal carcinoma of the breast.

Journal: Cancer science

Published: September 02, 2009

Grading system for lymph vessel tumor emboli: significant outcome predictor for invasive ductal carcinoma of the breast.

Grading system for lymph vessel tumor emboli: significant outcome predictor for invasive ductal carcinoma of the breast.

Journal: Human pathology

Published: August 19, 2009

p53 expression in tumor-stromal fibroblasts is closely associated with the nodal metastasis and outcome of patients with invasive ductal carcinoma who received neoadjuvant therapy.

p53 expression in tumor-stromal fibroblasts is closely associated with the nodal metastasis and outcome of patients with invasive ductal carcinoma who received neoadjuvant therapy.

Journal: Human pathology

Published: April 10, 2009

Histopathologic factors significantly associated with initial organ-specific metastasis by invasive ductal carcinoma of the breast: a prospective study.

Histopathologic factors significantly associated with initial organ-specific metastasis by invasive ductal carcinoma of the breast: a prospective study.

Journal: Human pathology

Published: July 01, 2007

Grading system for lymph vessel tumor emboli for prediction of the outcome of invasive ductal carcinoma of the breast.

Grading system for lymph vessel tumor emboli for prediction of the outcome of invasive ductal carcinoma of the breast.

Journal: Human pathology

Published: March 21, 2007

Primary tumor/vessel tumor/nodal tumor classification of extrahepatic bile duct carcinoma.

Primary tumor/vessel tumor/nodal tumor classification of extrahepatic bile duct carcinoma.

Journal: Human pathology

Published: November 30, 2006

Showing 1-12 of 13

Last Updated: 09/26/2026